Company intelligence / Profile preview

German Cooperative Clinical Grug Research and Development

Hoppegarten, Brandenburg, Germany
Ownership
Private
Employees
~16
Development stage
Other
01

Overview

CCDRD has completed clinical trials for recombinant human insulins and parathyroid hormone, and is participating in clinical development of biosimilars and G-CSF formulations

Therapeutic areas
OncologyEndocrinologyImmunology
Modalities
recombinant proteinsbiosimilarsbiologics
Industry
Contract Research Organization

Beyond the preview

Go deeper on German Cooperative Clinical Grug Research and Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on German Cooperative Clinical Grug Research and Development.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call